Patents by Inventor Chuiyee Yap

Chuiyee Yap has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230374603
    Abstract: Described herein are compounds, compositions and methods for treatment of cancer. Also described are methods and uses for identifying subject with cancer that are suitable for treatment with the compounds, composition and methods are described herein.
    Type: Application
    Filed: March 24, 2023
    Publication date: November 23, 2023
    Applicant: PACYLEX PHARMACEUTICALS INC.
    Inventors: Luc G. Berthiaume, Conganige Maneka Anne Perinpanayagam, Chuiyee Yap, Erwan Beauchamp
  • Publication number: 20220023294
    Abstract: Described herein are compounds, compositions and methods for treatment of cancer. Also described are methods and uses for identifying subject with cancer that are suitable for treatment with the compounds, composition and methods are described herein. In one aspect of the present invention, there is provided a method of treating a subject having a cancer deficient in NMT2, comprising: administering to said subject an NMT inhibitor.
    Type: Application
    Filed: October 1, 2021
    Publication date: January 27, 2022
    Applicant: PACYLEX PHARMACEUTICALS INC.
    Inventors: Luc G. Berthiaume, Erwan Beauchamp, Conganige Maneka Anne Perinpanayagam, Chuiyee Yap
  • Patent number: 11135218
    Abstract: Described herein are compounds, compositions and methods for treatment of cancer. Also described are methods and uses for identifying subject with cancer that are suitable for treatment with the compounds, composition and methods are described herein. In one aspect of the present invention, there is provided a method of treating a subject having a cancer deficient in NMT2, comprising: administering to said subject an NMT inhibitor.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: October 5, 2021
    Assignee: PACYLEX PHARMACEUTICALS INC.
    Inventors: Luc G. Berthiaume, Erwan Beauchamp, Conganige Maneka Anne Perinpanayagam, Chuiyee Yap
  • Publication number: 20190010555
    Abstract: Described herein are compounds, compositions and methods for treatment of cancer. Also described are methods and uses for identifying subject with cancer that are suitable for treatment with the compounds, composition and methods are described herein.
    Type: Application
    Filed: April 2, 2018
    Publication date: January 10, 2019
    Applicant: PACYLEX PHARMACEUTICALS INC.
    Inventors: Luc G. Berthiaume, Conganige Maneka Anne Perinpanayagam, Chuiyee Yap, Erwan Beauchamp
  • Publication number: 20190000838
    Abstract: Described herein are compounds, compositions and methods for treatment of cancer. Also described are methods and uses for identifying subject with cancer that are suitable for treatment with the compounds, composition and methods are described herein. In one aspect of the present invention, there is provided a method of treating a subject having a cancer deficient in NMT2, comprising: administering to said subject an NMT inhibitor.
    Type: Application
    Filed: July 2, 2018
    Publication date: January 3, 2019
    Applicant: PACYLEX PHARMACEUTICALS INC.
    Inventors: Luc G. Berthiaume, Erwan Beauchamp, Conganige Maneka Anne Perinpanayagam, Chuiyee Yap
  • Publication number: 20150275309
    Abstract: Described herein are compounds, compositions and methods for treatment of cancer. Also described are methods and uses for identifying subject with cancer that are suitable for treatment with the compounds, composition and methods are described herein.
    Type: Application
    Filed: October 30, 2013
    Publication date: October 1, 2015
    Inventors: Luc G. Berthiaume, Conganige Maneka Anne Perinpanayagam, Chuiyee Yap, Erwan Beauchamp
  • Publication number: 20140227284
    Abstract: Described herein are compounds, compositions and methods for treatment of cancer. Also described are methods and uses for identifying subject with cancer that are suitable for treatment with the compounds, composition and methods are described herein. In one aspect of the present invention, there is provided a method of treating a subject having a cancer deficient in NMT2, comprising: administering to said subject an NMT inhibitor.
    Type: Application
    Filed: July 23, 2012
    Publication date: August 14, 2014
    Applicant: PACYLEX PHARMACEUTICALS INC.
    Inventors: Luc G. Berthiaume, Erwan Beauchamp, Conganige Maneka Anne Perinpanayagam, Chuiyee Yap